Halozyme Therapeutics
HALO
#2004
Rank
S$10.39 B
Marketcap
$82.09
Share price
1.16%
Change (1 day)
53.50%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of June 2024 : S$2.56 B

According to Halozyme Therapeutics's latest financial reports the company's total assets are S$2.56 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$2.28 B-7.27%
2022-12-31S$2.46 B65.75%
2021-12-31S$1.48 B94.27%
2020-12-31S$0.76 B0.76%
2019-12-31S$0.76 B26.88%
2018-12-31S$0.59 B-13.76%
2017-12-31S$0.69 B83.74%
2016-12-31S$0.37 B47.06%
2015-12-31S$0.25 B17.36%
2014-12-31S$0.21 B70.01%
2013-12-31S$0.12 B-21.76%
2012-12-31S$0.16 B93.6%
2011-12-31S$85.16 M-27.66%
2010-12-31S$0.11 B8.58%
2009-12-31S$0.10 B-1.52%
2008-12-31S$0.11 B-26.4%
2007-12-31S$0.14 B111.66%
2006-12-31S$70.67 M106.96%
2005-12-31S$34.14 M41.18%
2004-12-31S$24.18 M2095.77%
2003-12-31S$1.1 M175.33%
2002-12-31S$0.4 M727.21%
2001-12-31S$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$0.57 B-77.46%๐Ÿ‡บ๐Ÿ‡ธ USA
S$93.61 B 3,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$34.27 B 1,236.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$281.60 B 10,877.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$181.17 B 6,962.63%๐Ÿ‡ซ๐Ÿ‡ท France
S$235.87 B 9,094.85%๐Ÿ‡บ๐Ÿ‡ธ USA